Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9312016 [patent_doc_number] => 08653234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides' [patent_app_type] => utility [patent_app_number] => 13/535303 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 35 [patent_no_of_words] => 21533 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535303 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/535303
Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides Jun 26, 2012 Issued
Array ( [id] => 8649117 [patent_doc_number] => 20130034848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'TUMOR SUPPRESSOR GENE P33ING2' [patent_app_type] => utility [patent_app_number] => 13/530070 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27818 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530070 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/530070
TUMOR SUPPRESSOR GENE P33ING2 Jun 20, 2012 Abandoned
Array ( [id] => 8453182 [patent_doc_number] => 20120264129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'K-ras Mutations and Anti-EGFr Antibody Therapy' [patent_app_type] => utility [patent_app_number] => 13/523174 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12523 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523174 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/523174
K-ras mutations and anti-EGFr antibody therapy Jun 13, 2012 Issued
Array ( [id] => 8567143 [patent_doc_number] => 20120329713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY' [patent_app_type] => utility [patent_app_number] => 13/489430 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 32208 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13489430 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/489430
METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY Jun 4, 2012 Abandoned
Array ( [id] => 8846442 [patent_doc_number] => 08455624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Methods and compositions for detecting endometrial or ovarian cancer' [patent_app_type] => utility [patent_app_number] => 13/487026 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26580 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487026 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/487026
Methods and compositions for detecting endometrial or ovarian cancer May 31, 2012 Issued
Array ( [id] => 9882762 [patent_doc_number] => 08969527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Recurrent gene fusions in prostate cancer' [patent_app_type] => utility [patent_app_number] => 13/483142 [patent_app_country] => US [patent_app_date] => 2012-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 38 [patent_no_of_words] => 46921 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13483142 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/483142
Recurrent gene fusions in prostate cancer May 29, 2012 Issued
Array ( [id] => 8502492 [patent_doc_number] => 20120301900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'APPARATUS AND METHOD FOR DETECTING TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 13/479987 [patent_app_country] => US [patent_app_date] => 2012-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6874 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479987 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/479987
APPARATUS AND METHOD FOR DETECTING TUMOR CELLS May 23, 2012 Abandoned
Array ( [id] => 8465634 [patent_doc_number] => 20120270802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'BINDING MOLECULES FOR THE TREATMENT OF MYELOID CELL MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 13/474456 [patent_app_country] => US [patent_app_date] => 2012-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27838 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474456 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/474456
Binding molecules for the treatment of myeloid cell malignancies May 16, 2012 Issued
Array ( [id] => 8381821 [patent_doc_number] => 20120225441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/473064 [patent_app_country] => US [patent_app_date] => 2012-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6085 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473064 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/473064
PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF May 15, 2012 Abandoned
Array ( [id] => 8381811 [patent_doc_number] => 20120225439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/472995 [patent_app_country] => US [patent_app_date] => 2012-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6085 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472995 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/472995
PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF May 15, 2012 Abandoned
Array ( [id] => 8382173 [patent_doc_number] => 20120225795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/473019 [patent_app_country] => US [patent_app_date] => 2012-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6085 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473019 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/473019
PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF May 15, 2012 Abandoned
Array ( [id] => 8381438 [patent_doc_number] => 20120225064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Sphingosine 1-Phosphate Antagonism' [patent_app_type] => utility [patent_app_number] => 13/471441 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16707 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471441 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/471441
Sphingosine 1-Phosphate Antagonism May 13, 2012 Abandoned
Array ( [id] => 8476740 [patent_doc_number] => 20120276147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'CTSP CANCER-TESTIS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 13/462351 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 31240 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462351 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/462351
CTSP cancer-testis antigens May 1, 2012 Issued
Array ( [id] => 8476597 [patent_doc_number] => 20120276004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS' [patent_app_type] => utility [patent_app_number] => 13/458788 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18750 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458788 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/458788
Human myeloid derived suppressor cell cancer markers Apr 26, 2012 Issued
Array ( [id] => 10912913 [patent_doc_number] => 20140315929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'HSP90 COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 14/113779 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 74345 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113779 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113779
HSP90 COMBINATION THERAPY Apr 26, 2012 Abandoned
Array ( [id] => 9582453 [patent_doc_number] => 08772455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Markers for identifying tumor cells, methods and kit thereof' [patent_app_type] => utility [patent_app_number] => 13/431919 [patent_app_country] => US [patent_app_date] => 2012-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15734 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13431919 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/431919
Markers for identifying tumor cells, methods and kit thereof Mar 26, 2012 Issued
Array ( [id] => 8495443 [patent_doc_number] => 20120294851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Cancer Therapies and Pharmaceutical Compositions Used Therein' [patent_app_type] => utility [patent_app_number] => 13/428885 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28209 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428885 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/428885
Cancer therapies and pharmaceutical compositions used therein Mar 22, 2012 Issued
Array ( [id] => 10032658 [patent_doc_number] => 09073964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers' [patent_app_type] => utility [patent_app_number] => 13/422936 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 9 [patent_no_of_words] => 18341 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422936 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/422936
Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers Mar 15, 2012 Issued
Array ( [id] => 10032658 [patent_doc_number] => 09073964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers' [patent_app_type] => utility [patent_app_number] => 13/422936 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 9 [patent_no_of_words] => 18341 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422936 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/422936
Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers Mar 15, 2012 Issued
Array ( [id] => 8405886 [patent_doc_number] => 20120237952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'MYOSIN-IIA S1943 PHOSPHORYLATION AS A MARKER OF TUMOR INVASION' [patent_app_type] => utility [patent_app_number] => 13/419805 [patent_app_country] => US [patent_app_date] => 2012-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4491 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13419805 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/419805
Myosin-IIA S1943 phosphorylation as a marker of tumor invasion Mar 13, 2012 Issued
Menu